
### [MONDO:0005374](http://purl.obolibrary.org/obo/MONDO_0005374)
**Label:** myeloproliferative disorder

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0013794](http://purl.obolibrary.org/obo/MONDO_0013794) (thrombocythemia 3), [MONDO:0011173](http://purl.obolibrary.org/obo/MONDO_0011173) (thrombocythemia 2), [MONDO:0009692](http://purl.obolibrary.org/obo/MONDO_0009692) (primary myelofibrosis), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0019454](http://purl.obolibrary.org/obo/MONDO_0019454) (refractory anemia with excess blasts), [MONDO:0019111](http://purl.obolibrary.org/obo/MONDO_0019111) (familial thrombocytosis), [MONDO:0019452](http://purl.obolibrary.org/obo/MONDO_0019452) (chronic myeloproliferative disease, unclassifiable), [MONDO:0008554](http://purl.obolibrary.org/obo/MONDO_0008554) (thrombocythemia 1), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0020312](http://purl.obolibrary.org/obo/MONDO_0020312) (atypical chronic myeloid leukemia), [MONDO:0005029](http://purl.obolibrary.org/obo/MONDO_0005029) (essential thrombocythemia), [MONDO:0007896](http://purl.obolibrary.org/obo/MONDO_0007896) (acute monocytic leukemia), [MONDO:0020076](http://purl.obolibrary.org/obo/MONDO_0020076) (myeloproliferative neoplasm), [MONDO:0011996](http://purl.obolibrary.org/obo/MONDO_0011996) (chronic myelogenous leukemia), [MONDO:0005171](http://purl.obolibrary.org/obo/MONDO_0005171) (chronic myeloproliferative disorder), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), [MONDO:0013667](http://purl.obolibrary.org/obo/MONDO_0013667) (myelodysplastic syndrome), [MONDO:0011118](http://purl.obolibrary.org/obo/MONDO_0011118) (acute myeloid leukemia), 

**Corr. equiv. classes:** [Orphanet:86839](http://www.orpha.net/ORDO/Orphanet_86839), [OMIM:187950](http://purl.obolibrary.org/obo/OMIM_187950), [Orphanet:52688](http://www.orpha.net/ORDO/Orphanet_52688), [OMIM:151380](http://purl.obolibrary.org/obo/OMIM_151380), [OMIM:601977](http://purl.obolibrary.org/obo/OMIM_601977), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:86830](http://www.orpha.net/ORDO/Orphanet_86830), [Orphanet:3318](http://www.orpha.net/ORDO/Orphanet_3318), [Orphanet:519](http://www.orpha.net/ORDO/Orphanet_519), [Orphanet:98836](http://www.orpha.net/ORDO/Orphanet_98836), [Orphanet:514](http://www.orpha.net/ORDO/Orphanet_514), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [Orphanet:71493](http://www.orpha.net/ORDO/Orphanet_71493), [Orphanet:98274](http://www.orpha.net/ORDO/Orphanet_98274), [OMIM:300331](http://purl.obolibrary.org/obo/OMIM_300331), [OMIM:601626](http://purl.obolibrary.org/obo/OMIM_601626), [Orphanet:29073](http://www.orpha.net/ORDO/Orphanet_29073), [OMIM:614286](http://purl.obolibrary.org/obo/OMIM_614286), [OMIM:131440](http://purl.obolibrary.org/obo/OMIM_131440), [OMIM:614521](http://purl.obolibrary.org/obo/OMIM_614521), [OMIM:254450](http://purl.obolibrary.org/obo/OMIM_254450), [Orphanet:168956](http://www.orpha.net/ORDO/Orphanet_168956), [Orphanet:824](http://www.orpha.net/ORDO/Orphanet_824), [Orphanet:314701](http://www.orpha.net/ORDO/Orphanet_314701), [Orphanet:98824](http://www.orpha.net/ORDO/Orphanet_98824), [OMIM:608232](http://purl.obolibrary.org/obo/OMIM_608232), [Orphanet:521](http://www.orpha.net/ORDO/Orphanet_521), [Orphanet:314962](http://www.orpha.net/ORDO/Orphanet_314962), 

**Class expressions from DL-Learner:**

- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology))) 46.69%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology))) 45.15%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face))) 44.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head))) 44.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology))) 43.77%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument))) 42.85%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin))) 42.85%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 42.85%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 41.84%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 40.40%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 40.40%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 40.40%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 40.37%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 38.54%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 36.80%


